Lomitapide Mesylate and Ogen 1.25

• Generic Name: lomitapide
• Dosage Forms: n.a.
• Other Brand Names: Juxtapid

Adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce LDL-cholesterol, total cholesterol, apolipoprotein B (apo B), and non-HDL-cholesterol concentrations in the management of homozygous familial hypercholesterolemia (designated an orphan drug by US FDA for use in this condition).

Safety and efficacy not established in patients with hypercholesterolemia who do not have homozygous familial hypercholesterolemia.

Effects on cardiovascular morbidity and mortality not established.

• Generic Name: estropipate
• Dosage Forms: n.a.
• Other Brand Names: Ogen 125, Ortho-Est, Ogen 0625, Ogen 25

Ogen 1.25 is a form of estrogen, a female sex hormone produced by the ovaries. Estrogen is necessary for many processes in the body.

Ogen 1.25 is used to treat menopause symptoms such as hot flashes and vaginal changes, and to prevent osteoporosis (bone loss) in menopausal women. This medicine is also used to replace estrogen in women with ovarian failure or other conditions that cause a lack of natural estrogen in the body.

Ogen 1.25 may also be used for purposes not listed in this medication guide.